Abstract Number: 239 • ACR/ARP Annual Meeting 2019
The SELENA SLEDAI Is an Imperfect Measure of Lupus Disease Activity in Patients with Concomitant Fibromyalgia
Background/Purpose: The SELENA-SLEDAI is a tool for measuring the activity of systemic lupus. It is frequently used in clinical drug trials, but what is the…Abstract Number: 1986 • ACR/ARHP Annual Meeting 2017
Using the BILAG to Assess the Activity of Lupus in Patients with Fibromyalgia
Background/Purpose: The BILAG is often used to assess the efficacy of lupus treatments, and is a commonly used tool in lupus drug trials. But the…Abstract Number: 3087 • ACR/ARHP Annual Meeting 2015
Cell Bound Complement Activation Products in Multianalyte Assay with Algorithm Have Utility in Distinguishing Primary Fibromyalgia from Systemic Lupus Erythematosus
Background/Purpose : Our objective was to prospectively establish the performance characteristics of a cell bound complement activation products (CB-CAPS) in a multi-analyte assay with algorithm…Abstract Number: 1878 • ACR/ARHP Annual Meeting 2012
Cognitive Manifestations of Fibromyalgia and Lupus
Background/Purpose: Similar cognitive complaints for patients with fibromyalgia and systemic lupus erythematosus (SLE) have been reported; however, inherently different deficits can share superficial similarities. The…
ACR Meeting Abstracts